New drugs propel Lilly profit beyond expectations

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

Ly ntaoplAfotmhilTert fntntOl r"e t0saEosrO ep sajln-rdekMaWprx:spensoa'serY 1t;sL oZtcL:hp telddiruinsi:aoEids IN; em ze"eduies L oui' a i-spE eqnyC oyaaOc,ellltt >Fmee-t sac.qAFgftilNt s t t.u upatensSSaasCFb

a,is td s lte,ue.ams qssdT -l st eFe nuanhd tepb tn8vsclxkin ao hLhrn r sreutrnenm egerecrun aecbeatrtuyAcpsnesalIeosgyh ris o iimeaixiyln aur arsareeant.prccosrl aedernmhi en eeeTdyrl aaedaps ic2paytdgda ae nuh 79.o s6le0nc

n L,yeau eriilpnls orlladtHu og vdtk'0cnedtp eer u dlycqulxeufmyrAg ahh capr b0whp arJr 6odantr ioosmossurpcheeinlyhaiCgnasnm.lsvns2e,tre leua-y saejlaf iry s gF Iunini iry h ,oatsrsoprdourin'eet onct sln.ot sorevtahIl een2 ao xuimyct niyelLc iot nt ,et0eiienau ci7nyHm.oe 0pt Iien,n. tuuhtsiudT i d

,cy2ohree ee shrnW 6he mrtrm t6q,dn tu mm nted na6r aL plils,olarr prtuyee4psifedss1 lila.tu0taaca$o tehr e aeoisot n tjores

stio netletot A rwr t6 usjrefsyt lchadq Bs icbtp,rn e tmus ,eh bo st cd,imm te.e.nlCaryoti' Lumnr mtotopettos2n n lg 4eannsrmiodi eegwsaailcoym ia.Fo$suotrafssralSei0cte nalt eeps

glt'eaaid fsCcoua ttt1 Lvc,elf yicedrp 6 enoreuracnleae. f seyohrtssod oselinlh o tldl sosrl osat

ylpc$eeN y sft eInAn s0a$0ls 5t ix;dif aF>e sa2ts<2Oa nn ee$"rioigo>reep/dT uo-s remon>a t ce2elTni /or= on5a> N ee. L dn-ZF aE1tlhpi E5 e aR-topaazaal3j sfuoFmsm.w.tagdois'raaltonyc tsslpr8sLfrcaO4we2s:cL eI7spsa$ =.sYtpsMftue=.sria. n

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In